Article

Glycemic Targeting

Author(s):

Peter Huckfeldt, PhD

In this video segment Dr. Huckfeldt discussed factors contributing to low levels of glycemic control. Patient, medication and physician factors can all effect medication adherence.

Glycemic control reduces the risks of complications in diabetes, but many patients with type 1 diabetes (T1D) still do not achieve their goals of glycemic control, said Dr. Peter Huckfeldt, PhD, Prodessor, Pardee RAND Graduate School. In this video segment Dr. Huckfeldt discussed factors contributing to low levels of glycemic control. Patient, medication and physician factors can all effect medication adherence.

Related Videos
dr jennifer green
dr jennifer green
dr ken cohen
dr ian neeland
Yael Mauer, MD, MPH
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Diana Isaacs, PharmD
Beau Raymond, MD
Robert Zimmerman, MD
Beau Raymond, MD
Related Content
FDA website | Image credit: Postmodern Studio – stock.adobe.com
December 20th 2024

FDA Rejects Sotagliflozin for Type 1 Diabetes; Lexicon Shifts Focus

Hayden E. Klein
The FDA issued a complete response letter for sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control.
Managed Care Cast logo
July 11th 2024

Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
AJMC Q&A with Ellen Francis, PhD | Background image credit: ipopba - stock.adobe.com
December 17th 2024

Early Diabetes Screening in Pregnancy: Challenges and Opportunities

Hayden E. Klein
Ellen Francis, PhD, discusses the benefits, challenges, and future implications of implementing earlier diabetes screening for pregnant women.
Managed Care Cast graphic
February 15th 2022

How Can Employers Leverage the DPP to Improve Diabetes Rates?

On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
The top 5 diabetes content of 2024
December 16th 2024

Top 5 Most-Viewed Diabetes Content of 2024

Hayden E. Klein
This year’s top diabetes content focused on pediatric metabolic health, misconceptions about weight loss drugs, and more.
Doctor measuring patient's blood pressure | Image credit: Andrey Popov – stock.adobe.com
November 19th 2024

Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes

Connor Iapoce
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo